Breast Cancer :: Herceptin for the treatment of postmenopausal patients with metastatic breast cancer
Herceptin receives positive opinion in Europe for use in combination with an aromatase inhibitor for the treatment of patients with HER2- and hormone receptor-positive metastatic breast cancer.